Literature DB >> 24603588

Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.

Jia-Huei Tsai1, Jau-Yu Liau1, Yu-Lin Lin2, Liang-In Lin3, Yi-Chen Cheng4, Mei-Ling Cheng5, Yung-Ming Jeng1.   

Abstract

Traditional serrated adenoma is one type of colorectal serrated neoplasm and a precursor of colorectal cancer. We evaluated the pathologic and molecular features of 60 traditional serrated adenomas with cytologic dysplasia and/or invasive carcinoma. On the basis of morphological features, 16 cases (27%) were categorized as traditional serrated adenoma with serrated dysplasia and 25 cases (42%) as traditional serrated adenoma with conventional adenomatous dysplasia. In addition, 19 cases (31%) showed an overall tubulovillous adenomatous structure but with focal serrated feature. Traditional serrated adenoma with serrated dysplasia had a significantly higher frequency of BRAF mutation than traditional serrated adenoma with conventional adenomatous dysplasia and tubulovillous adenoma with serrated feature (P=0.006), whereas traditional serrated adenoma with conventional adenomatous dysplasia and tubulovillous adenoma with serrated feature had higher frequencies of KRAS mutation than traditional serrated adenoma with serrated dysplasia (P<0.0001). Only traditional serrated adenoma with serrated dysplasia showed sessile serrated adenoma-like lesions at the periphery (n=3) and developed invasive carcinomas when the lesions were <15 mm in size. Abnormal nuclear accumulation of β-catenin was detected in traditional serrated adenoma with conventional adenomatous dysplasia and tubulovillous adenoma with serrated feature but not in traditional serrated adenoma with serrated dysplasia. The frequency of the positive CpG island methylator phenotype was similar among the three dysplastic subtypes, and immunostaining of four mismatch repair proteins in the nucleus was retained in all traditional serrated adenomas and associated invasive malignancies. Traditional serrated adenoma-associated adenocarcinomas (n=28) displayed distinctive morphological features: oval cell nuclei, serrated glands, infiltrating borders, rare occurrences of necrosis and mucinous differentiation. Overexpression of p53 was detected only in high-grade dysplasia and invasive adenocarcinoma. Our findings indicate that traditional serrated adenoma is a heterogeneous neoplasm with two pathways of neoplastic progression, which are distinct from the sessile serrated pathway of colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24603588     DOI: 10.1038/modpathol.2014.35

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  21 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach.

Authors:  Charly Liddell; Laure Droy-Dupré; Sylvie Métairie; Fabrice Airaud; Christelle Volteau; Stéphane Bezieau; Christian L Laboisse; Jean-François Mosnier
Journal:  Mod Pathol       Date:  2017-04-21       Impact factor: 7.842

3.  BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer.

Authors:  Kuo-Hsing Chen; Yu-Lin Lin; Jau-Yu Liau; Jia-Huei Tsai; Li-Hui Tseng; Liang-In Lin; Jin-Tung Liang; Been-Ren Lin; Ji-Shiang Hung; Yih-Leong Chang; Kun-Huei Yeh; Ann-Lii Cheng
Journal:  Med Oncol       Date:  2016-03-31       Impact factor: 3.064

Review 4.  Applying Precision to the Management of BRAF-Mutant Metastatic Colorectal Cancer.

Authors:  Benny Johnson; Scott Kopetz
Journal:  Target Oncol       Date:  2020-10       Impact factor: 4.493

5.  Clinicopathological and molecular correlations in traditional serrated adenoma.

Authors:  Shigeki Sekine; Satoshi Yamashita; Masayoshi Yamada; Taiki Hashimoto; Reiko Ogawa; Hiroshi Yoshida; Hirokazu Taniguchi; Motohiro Kojima; Toshikazu Ushijima; Yutaka Saito
Journal:  J Gastroenterol       Date:  2020-02-12       Impact factor: 7.527

6.  Gastric and small intestinal traditional serrated adenomas: a detailed morphologic and immunohistochemical analysis.

Authors:  Saba Kiremitçi; Cevriye Cansız Ersöz; Berna Savaş; Arzu Ensari
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

Review 7.  Serrated neoplasia-role in colorectal carcinogenesis and clinical implications.

Authors:  Joep E G IJspeert; Louis Vermeulen; Gerrit A Meijer; Evelien Dekker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-12       Impact factor: 46.802

Review 8.  The Serrated Polyp Pathway: Is It Time to Alter Surveillance Guidelines?

Authors:  Brendon O'Connell; Nazar Hafiz; Seth Crockett
Journal:  Curr Gastroenterol Rep       Date:  2017-08-29

9.  A clinicopathological and molecular analysis of 200 traditional serrated adenomas.

Authors:  Mark L Bettington; Neal I Walker; Christophe Rosty; Ian S Brown; Andrew D Clouston; Diane M McKeone; Sally-Ann Pearson; Kerenaftali Klein; Barbara A Leggett; Vicki L J Whitehall
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

10.  Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.

Authors:  Jung Ho Kim; Jeong Mo Bae; Nam-Yun Cho; Gyeong Hoon Kang
Journal:  Oncotarget       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.